Advertisement

Topics

Fujirebio Inc. Company Profile

00:31 EDT 24th May 2018 | BioPortfolio

Founded in 1950, Fujirebio Inc. is an international leading diagnostic supplier, a part of Miraca Group, Japan’s leading healthcare group with its focus on clinical laboratory testing services and products. Fujirebio is specialized in development, commercialization, import and export of diagnostic reagent and instruments. For more about Fujirebio, visit https://www.fujirebio-us.com/.


News Articles [10 Associated News Articles listed on BioPortfolio]

Janssen gets rights to Fujirebio assay for use in Alzheimer's

Miraca Holdings’ Fujirebio Inc. licensed Janssen Pharmaceuticals Inc. rights to develop and commercialize an amyloid beta 42/40 ratio assay that will run on Fujirebio’s Lumipulse chemiluminescent ...

Fujirebio and Janssen Partner to Develop An Assay to Identify Patients that may Benefit from Janssen’s Investigational Alzheimer’s Disease Drug

MALVERN, Pa.–(BUSINESS WIRE)–Fujirebio Inc., a consolidated subsidiary of Miraca Holdings Inc., (Head office: Shinjuku-ku, Tokyo, President and CEO: Yoshihiro Ashihara, hereinafter “Fuji...

Fujirebio, Janssen sign deal to develop AMYLOID ß 42/40 RATIO assay

Miraca’s consolidated subsidiary Fujirebio has signed an agreement with US-based Janssen Pharmaceuticals for the development and commercialization of an AMYLOID β 42/40 RATIO assay.

Fujirebio Enters into Agreement with Janssen Pharmaceuticals to Develop and Commercialize AMYLOID β 42/40 RATIO Assay

Fujirebio Inc., a consolidated subsidiary of Miraca Holdings Inc., (Head office: Shinjuku-ku, Tokyo, President and CEO: Yoshihiro Ashihara, hereinafter “Fujirebio” or “the C...

Global and North America PSA Test Market Status and Future Forecast 20132023 [Report Updated: 07022018] Prices from USD $2500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Fujirebio Diagnostics Inc Medical Equipment Deals and Alliances Profile [Report Updated: 27112017] Prices from USD $250

SummaryFujirebio Diagnostics Inc FDI, a subsidiary of Fujirebio Inc is a healthcare diagnostic company that develops, manufactures and markets invitro diagnostic products and biomarker assays. The com...

Global Octocrylene Market Research Report 2018 [Report Updated: 16012018] Prices from USD $3500

SummaryMarket Segment as follows:By Region AsiaPacific Segment by Company, Type and Application North America Segment by Company, Type and Application Europe Segment by Company, Type and Appl...

20152023 World PSA Test Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 10012018] Prices from USD $2800

SummaryProstatespecific antigen PSA, also known as gammaseminoprotein or kallikrein3 KLK3, is a glycoprotein enzyme encoded in humans by the KLK3 gene.The PSA test measures the level of PSA in a man's...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Fujirebio Inc.

Founded in 1950, Fujirebio Inc. is an international leading diagnostic supplier, a part of Miraca Group, Japan’s leading healthcare group with its focus on clinical laborator...

Fujirebio Diagnostics,Inc

Formerly Certocor Diagnostics,Fujirebio Diagnostics,Inc.was acquired by ourparent company Fujirebio,Inc.of Tokyo,Japan in November 1998.

JFK Communications, Inc.

Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, manufacturing and co...

Gold Standard Diagnostics, Corp.

Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, ...

Fujirebio Diagnostics Inc.

More Information about "Fujirebio Inc." on BioPortfolio

We have published hundreds of Fujirebio Inc. news stories on BioPortfolio along with dozens of Fujirebio Inc. Clinical Trials and PubMed Articles about Fujirebio Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fujirebio Inc. Companies in our database. You can also find out about relevant Fujirebio Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record